FDA
approval
· 2020-02-28
FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)
Summary
The FDA approved a supplemental application for AUBAGIO (teriflunomide) submitted by Genzyme Corporation. This action updates the approved labeling/indication f…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AUBAGIO (TERIFLUNOMIDE)